• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠外营养患者的植物甾醇血症:对肝病发展的影响。

Phytosterolemia in parenteral nutrition patients: implications for liver disease development.

作者信息

Llop Josep M, Virgili Núria, Moreno-Villares José M, García-Peris Pilar, Serrano Teresa, Forga Maria, Solanich Joan, Pita Ana M

机构信息

Department of Pharmacy and Endocrinology, Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain.

出版信息

Nutrition. 2008 Nov-Dec;24(11-12):1145-52. doi: 10.1016/j.nut.2008.06.017. Epub 2008 Jul 24.

DOI:10.1016/j.nut.2008.06.017
PMID:18656327
Abstract

OBJECTIVE

Phytosterols present in parenteral nutrition (PN) lipid emulsions have been linked to phytosterolemia and cholestatic liver disease, although no direct relation has been established. We investigated the relation among plasma phytosterol (PY) infused, total plasma PY levels, and possible links to PN-associated liver disease.

METHODS

Twenty-seven adult patients on home PN were enrolled in the study. PYs were measured in plasma and lipid emulsions by gas chromatography. Liver function tests and blood counts were assessed to identify hepatic impairment, and biopsies were performed in eight patients.

RESULTS

Mean total plasma PY level was higher in patients than in controls (55.4 +/- 6.2 versus 14.8 +/- 2.3 microg/mL). Simple linear regression models showed a correlation among total plasma PY, liver function tests, and platelet counts, which was stronger for total bilirubin (r(2) = 0.53, P = 0.0001) and aspartate aminotransferase (r(2) = 0.50, P = 0.0001) and weaker for platelet counts (r(2) = 0.158, P = 0.04); between infused lipid and liver function tests, the correlation was significant for total bilirubin (r(2) = 0.19, P = 0.038) and aspartate aminotransferase (r(2) = 0.164, P = 0.049). In multiple linear regression analysis, a decreased oral diet (b = -52.3, P = 0.001) and infused PY (b = 2.54, P = 0.093) were risk factors for high plasma PY levels (r(2) = 0.54). Biopsies showed moderate to severe liver impairment in five patients.

CONCLUSION

Liver damage may be linked to high plasma PY levels and strengthened by lack of an oral diet in patients on home PN.

摘要

目的

肠外营养(PN)脂质乳剂中存在的植物甾醇与植物甾醇血症和胆汁淤积性肝病有关,尽管尚未建立直接关联。我们研究了输注的血浆植物甾醇(PY)、血浆总PY水平之间的关系,以及与PN相关肝病的可能联系。

方法

27名接受家庭PN的成年患者纳入本研究。通过气相色谱法测量血浆和脂质乳剂中的PY。评估肝功能测试和血细胞计数以识别肝损伤,并对8名患者进行活检。

结果

患者的平均血浆总PY水平高于对照组(55.4±6.2对14.8±2.3微克/毫升)。简单线性回归模型显示血浆总PY、肝功能测试和血小板计数之间存在相关性,总胆红素(r² = 0.53,P = 0.0001)和天冬氨酸转氨酶(r² = 0.50,P = 0.0001)的相关性更强,血小板计数的相关性较弱(r² = 0.158,P = 0.04);在输注的脂质与肝功能测试之间,总胆红素(r² = 0.19,P = 0.038)和天冬氨酸转氨酶(r² = 0.164,P = 0.049)的相关性显著。在多元线性回归分析中,口服饮食减少(b = -52.3,P = 0.001)和输注的PY(b = 2.54,P = 0.093)是血浆PY水平升高的危险因素(r² = 0.54)。活检显示5名患者有中度至重度肝损伤。

结论

肝损伤可能与血浆PY水平升高有关,并且家庭PN患者缺乏口服饮食会加剧这种情况。

相似文献

1
Phytosterolemia in parenteral nutrition patients: implications for liver disease development.肠外营养患者的植物甾醇血症:对肝病发展的影响。
Nutrition. 2008 Nov-Dec;24(11-12):1145-52. doi: 10.1016/j.nut.2008.06.017. Epub 2008 Jul 24.
2
Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease.接受肠外营养相关胆汁淤积性肝病的儿童中的植物甾醇血症
Gastroenterology. 1993 Dec;105(6):1806-13. doi: 10.1016/0016-5085(93)91079-w.
3
Parenteral plant sterols and intestinal failure-associated liver disease in neonates.肠外植物固醇与新生儿肠衰竭相关肝病。
J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):803-11. doi: 10.1097/MPG.0b013e3182474118.
4
High serum phytosterol levels in short bowel patients on parenteral nutrition support.接受肠外营养支持的短肠综合征患者血清植物甾醇水平升高。
Clin Nutr. 2005 Jun;24(3):415-20. doi: 10.1016/j.clnu.2005.01.001.
5
Factors associated to hypermanganesemia in patients receiving home parenteral nutrition.接受家庭肠外营养患者高锰血症的相关因素。
Clin Nutr. 2000 Oct;19(5):343-8. doi: 10.1054/clnu.2000.0120.
6
Sterol profiling in red blood cell membranes and plasma of newborns receiving total parenteral nutrition.
J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):645-51. doi: 10.1097/MPG.0b013e318170956a.
7
Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease.基于橄榄油的脂质乳剂在家庭肠外营养相关肝病特定情况下的潜在用途。
Clin Nutr. 2004 Dec;23(6):1418-25. doi: 10.1016/j.clnu.2004.08.011.
8
Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition.接受基于葡萄糖和基于脂质的肠外营养的患者会出现类似的肝功能异常。
Am J Gastroenterol. 1983 Apr;78(4):199-202.
9
[Hepatobiliary complications of total parenteral nutrition].[全胃肠外营养的肝胆并发症]
Chirurgie. 1992;118(1-2):47-53; discussion 53-4.
10
[Biological hepatic abnormalities, cholestatic jaundice and hospital artificial nutrition. A comparative study in adults with cyclic total parenteral nutrition and enteral nutrition].[生物性肝脏异常、胆汁淤积性黄疸与医院人工营养。成人周期性全胃肠外营养与肠内营养的比较研究]
Gastroenterol Clin Biol. 1988 Apr;12(4):326-31.

引用本文的文献

1
Intestinal failure-associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study.接受家庭肠外营养的成年慢性肠衰竭患者的肠衰竭相关性肝病:一项描述性队列研究。
JPEN J Parenter Enteral Nutr. 2025 May;49(4):507-516. doi: 10.1002/jpen.2746. Epub 2025 Mar 16.
2
Blood Phytosterol Concentration and Genetic Variant Associations in a Sample Population.血植物固醇浓度与样本人群中遗传变异的关联。
Nutrients. 2024 Apr 5;16(7):1067. doi: 10.3390/nu16071067.
3
Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review.
目前关于肠衰竭相关肝病(IFALD)的认识:一篇叙述性综述。
Nutrients. 2023 Jul 17;15(14):3169. doi: 10.3390/nu15143169.
4
Parenteral Nutrition, Sepsis, Acute Heart Failure and Hepatotoxic Drugs Are Related to Liver Test Disturbances in Critically Ill Patients.肠外营养、脓毒症、急性心力衰竭和肝毒性药物与危重症患者的肝试验紊乱有关。
Nutrients. 2023 Jun 2;15(11):2612. doi: 10.3390/nu15112612.
5
Inflammatory processes involved in the alteration of liver function biomarkers in adult hospitalized patients treated with parenteral nutrition.接受肠外营养治疗的成年住院患者肝功能生物标志物改变所涉及的炎症过程。
Front Nutr. 2023 Jan 27;10:1034481. doi: 10.3389/fnut.2023.1034481. eCollection 2023.
6
Evaluation of Emulsifying Ability of Phospholipids by Langmuir Monolayers and Stability of High Oil Ratio O/W Emulsions.评价磷脂的乳化能力通过 Langmuir 单分子层和高油比 O/W 乳液的稳定性。
AAPS PharmSciTech. 2022 Jul 28;23(6):208. doi: 10.1208/s12249-022-02325-6.
7
New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature.成人肠衰竭相关肝病的新见解:文献综述。
Saudi J Gastroenterol. 2021 Jan-Feb;27(1):3-12. doi: 10.4103/sjg.sjg_551_20.
8
Composition and Functionality of Lipid Emulsions in Parenteral Nutrition: Examining Evidence in Clinical Applications.肠外营养中脂质乳剂的组成与功能:临床应用中的证据审视
Front Pharmacol. 2020 Apr 29;11:506. doi: 10.3389/fphar.2020.00506. eCollection 2020.
9
An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure-Associated Liver Disease in Infants With Intestinal Failure.一项关于 Smoflipid 与 Intralipid 对肠衰竭相关肝病在肠衰竭婴儿中演变影响的观察性研究。
JPEN J Parenter Enteral Nutr. 2020 May;44(4):688-696. doi: 10.1002/jpen.1692. Epub 2019 Aug 25.
10
FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease.法尼醇X受体激动作用可在肠衰竭相关性肝病大鼠模型中预防肝损伤。
J Clin Transl Res. 2017 Oct 15;3(3):318-327. eCollection 2018 Jan 15.